PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-12-04

Date Title Company
04-Dec-2023 Food And Drug Administration Grants Two New Label Changes To Tirosint®-Sol (Levothyroxine Sodium) Oral Solution Businesswire
04-Dec-2023 Digital Health Strategies Closes Series A Funding Round to Expand Its Share of Health™ Patient Loyalty Platform Businesswire
04-Dec-2023 Orano Med Announces Appointment of Dr. Volker Wagner as Chief Medical Officer Businesswire
04-Dec-2023 CARMAT Announces the Opening of Its New Production Facility in Bois-d'Arcy, France Businesswire
04-Dec-2023 Medefil Announces Availability of FDA-Approved Emergency Syringes, Atropine Sulfate Injection, USP, and 10% Calcium Chloride Injection, USP Businesswire
04-Dec-2023 Clever Carnivore Raises $7M to Expand Operations and Scale Up Production of Cultivated Meat Businesswire
04-Dec-2023 Stem Cell Technologies and Applications Global Market Report 2023-2033 - Growing Government Support Driving Market Growth - ResearchAndMarkets.com Businesswire
04-Dec-2023 Nantworks AirStrip® and GE HealthCare Announce Agreement to Commercialize Integrated Patient Monitoring and Cardiac Data Visualization for Healthcare Systems Businesswire
04-Dec-2023 Wilson Sonsini Goodrich & Rosati Elects 20 New Partners Businesswire
04-Dec-2023 NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity Businesswire
04-Dec-2023 Devonian Bolsters Leadership Team and Aligns Strategy to Accelerate Clinical Development and Drive Revenue Growth and Commercial Success Businesswire
04-Dec-2023 Celyad Announces Management Change Businesswire
04-Dec-2023 UK’S National Institute for Health and Care Excellence (NICE) Selects CEL-SCI’s Multikine as Potential New Standard of Care for Head & Neck Cancer Businesswire
04-Dec-2023 QPS Holdings, LLC Expands Operations in Springfield, Missouri Businesswire
04-Dec-2023 Arcturus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference Businesswire
04-Dec-2023 Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers Businesswire
04-Dec-2023 Merck Strengthens Oncology Portfolio Through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib Businesswire
04-Dec-2023 Merck KGaA, Darmstadt, Germany Strengthens Oncology Portfolio Through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib Businesswire
04-Dec-2023 Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma Businesswire
04-Dec-2023 Eikon Therapeutics Announces the Election of Robert L. Huffines to its Board of Directors Businesswire